Summary
- Current Price
- As of today, IMNM price is $27.20, up +2.95% on
- Current Price All-Time High
- IMNM price is currently -57.35% below its historical high of $63.78 set on
- Market Cap
- IMNM current market cap is $3B, up +257.18% over the past 365 days
- Revenue
- IMNM current annual revenue is $6.94M, down -23.23% year-over-year
- Next Earnings
- The next earnings release for IMNM is on
Profile
| Metric | Value |
|---|---|
| Full Name | Immunome, Inc. |
| Ticker | NASDAQ: IMNM |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | immunome.com |
| Employees | 131 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| Price | $27.20 | |
| Price, 1D Change | +2.95% | |
| $3B | ||
| - | ||
| - | ||
| 1.68 | ||
| $6.94M | ||
| Revenue, 1Y Change | -23.23% | |
| -$2.43 | ||
| EPS, 1Y Change | +51.33% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$2.43 | ||
| EPS Estimate | -$2.31 | N/A |
| EPS Est. Change | +4.97% | N/A |
| $6.94M | ||
| Revenue Estimate | $444.44K | N/A |
| Revenue Est. Change | -93.60% | N/A |
| Current Price | $27.20 | |
| Price Target | $36.00 | - |
| Price Tgt. Change | +32.35% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$4.15 | -$5.00 | -20.39% | |
| -$2.21 | -$2.43 | -10.10% | |
| -$2.31 | N/A | +4.97% | |
| -$2.48 | N/A | -1.96% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $9.41M | $9.04M | -3.88% | |
| $7.70M | $6.94M | -9.90% | |
| $444.44K | N/A | -93.60% | |
| $59.70M | N/A | +760.15% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Value | Date |
|---|---|---|
| Current Price | $27.20 | |
| $21.45 | ||
| $22.12 | ||
| $20.52 | ||
| $23.23 | ||
| $1.30 | ||
| 1.68 | ||
| $1.41 | ||
| 66.56 | ||
| 65.96% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $6.94M | ||
| -$2.43 | ||
| $3.99M | ||
| 57.43% | ||
| -$214.11M | ||
| -3,084.76% | ||
| -$212.39M | ||
| -3,059.99% | ||
| -$211.16M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.01 | ||
| 14.69 | ||
| 14.69 | ||
| - | ||
| - | ||
| 36.51 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 769.44 | ||
| 5.25 | ||
| -11.12 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $634.34M | ||
| $653.48M | ||
| $683.19M | ||
| $660.78M | ||
| $48.85M | ||
| $44.99M | ||
| $3.86M | ||
| $0.00 | ||
| $3.34M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $219.34M | ||
| $218.10M | ||
| $2.96M | ||
| $0.00 | ||
| $2.96M | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$190.92M | ||
| $60.80M | ||
| $640.36M | ||
| $9.69M | ||
| -$200.60M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| Wedbush | → | |
| Truist Securities | → | |
| Wedbush | → | |
| Wedbush | → | |
| Truist Securities | → | |
| Barclays | ||
| Leerink Partners | → | |
| HC Wainwright & Co. | → | |
| Stephens & Co. | → | |
| Craig-Hallum | → |
Analyst sentiment
Institutional ownership
No data
Screeners with IMNM
FAQ
- What is the ticker symbol for Immunome, Inc.?
- The ticker symbol for Immunome, Inc. is NASDAQ:IMNM
- Does Immunome, Inc. pay dividends?
- No, Immunome, Inc. does not pay dividends
- What sector is Immunome, Inc. in?
- Immunome, Inc. is in the Healthcare sector
- What industry is Immunome, Inc. in?
- Immunome, Inc. is in the Biotechnology industry
- What country is Immunome, Inc. based in?
- Immunome, Inc. is headquartered in United States
- When did Immunome, Inc. go public?
- Immunome, Inc. initial public offering (IPO) was on October 2, 2020
- Is Immunome, Inc. in the S&P 500?
- No, Immunome, Inc. is not included in the S&P 500 index
- Is Immunome, Inc. in the NASDAQ 100?
- No, Immunome, Inc. is not included in the NASDAQ 100 index
- Is Immunome, Inc. in the Dow Jones?
- No, Immunome, Inc. is not included in the Dow Jones index
- When was Immunome, Inc. last earnings report?
- Immunome, Inc.'s most recent earnings report was on August 11, 2026
- When does Immunome, Inc. report earnings?
- The next expected earnings date for Immunome, Inc. is November 5, 2026
Data Sources & References
- IMNM Official Website immunome.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1472012/000119312526088172/0001193125-26-088172-index.htm
- IMNM Profile on Yahoo Finance finance.yahoo.com/quote/IMNM
- IMNM Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/imnm
